15-deoxy-Δ12,14-prostaglandin j2 suppresses rantes expression by inhibiting nadph oxidase activation in helicobacter pylori-infected gastric epithelial cells

Journal of Physiology and Pharmacology

Volumn 62, Issue 2, 2011, Pages 167-174

  Cha, B ^a   Lim, J W ^b   Kim, K H ^a   Kim, H ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

15 deoxy 12,14 prostaglandin j2; Helicobacter pylori; Human stomach adenocarcinoma (ags) cells; Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase; RANTES

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; DIPHENYLIODONIUM SALT; HYDROGEN PEROXIDE; JANUS KINASE 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT3 PROTEIN; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; ANTIINFECTIVE AGENT; CCL5 PROTEIN, HUMAN; DRUG DERIVATIVE; PROSTAGLANDIN D2;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; STOMACH ACID SECRETION; STOMACH EPITHELIUM; BIOSYNTHESIS; COMPARATIVE STUDY; DOWN REGULATION; DRUG ANTAGONISM; ENZYMOLOGY; EPITHELIUM CELL; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; STOMACH MUCOSA; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; CELL LINE, TUMOR; CHEMOKINE CCL5; DOWN-REGULATION; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NADPH OXIDASE; PROSTAGLANDIN D2;

EID: 79959338435     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302-1305.
2. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-terminal recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992; 116: 705-708.
3. Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric carcinogenesis. J Physiol Pharmacol 2009; 60: 3-21.
4. Chiozzi V, Mazzini G, Oldani A, et al. Relationship between Vac A toxin and ammonia in Helicobacter pylori-induced apoptosis in human gastric epithelial cells. J Physiol Pharmacol 2009; 60: 23-30.
5. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1992; 325: 1127-1131.
6. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
7. Mori N, Krensky AM, Geleziunas R, et al. Helicobacter pylori induces RANTES through activation of NF-kB. Infect Immun 2003; 71: 3748-3756.
8. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64: 959-966.
9. Kim H, Seo JY, Kim KH. Inhibition of lipid peroxidation, NF-kB activation and IL-8 production by Helicobacter pylori-stimulated gastric epithelial cells by rebamipide. Dig Dis Sci 2000; 45: 621-628.
10. Seo JY, Kim KH, Kim H. Role of oxidant-sensitive transcription factors on Helicobacter pylori-induced IL-8 expression in gastric epithelial AGS cells. Kor J Helicobacter Gastroint Res 2005; 5: 124-133.
11. Kim H, Seo JY, Kim KH. Effects of mannitol and dimethylthiourea on Helicobacter pylori-induced IL-8 production in gastric epithelial cells. Pharmacology 1999; 59: 201-211.
12. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-344.
13. Dorseuil O, Quinn MT, Bokoch GM. Dissociation of Rac translocation from p47phox /p67phox movements in human neutrophils by tyrosine kinase inhibitors. J Leukoc Biol 1995; 58: 108-113.
14. Koga H, Terasawa H, Nunoi H, Takeshige K, Inagaki F, Sumimoto H. Tetratricopeptide repeat (TPR) motifs of p67phox participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 1999; 274: 25051-25060.
15. Cha B, Lim JW, Kim KH, Kim H. HSP90beta interacts with Rac1 to activate NADPH oxidase in Helicobacter pyloriinfected gastric epithelial cells. Int J Biochem Cell Biol 2010; 42: 1455-1461.
16. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994; 76: 253-262.
17. Igaz P, Toth S, Falus A. Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflamm Res 2001; 50: 435-441.
18. Kovarik P, Mangold M, Ramsauer K, et al. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J 2001; 20: 91-100.
19. Wen Z, Zhong Z, Darnell JE. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241-250.
20. Shuai K, Liu B. Regulation of JAK-STAT signaling in the immune system. Nature Rev 2003; 3: 900-911.
21. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
22. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
23. Giri S, Rattan R, Singh AK, Singh I. The 15-deoxydelta12,14- prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NFkappaB- p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol 2004; 173: 5196-5208.
24. Hinz B, Brune K, Pahl A. 15-deoxy-delta(12,14)- prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gammaindependent mechanism. Biochem Biophys Res Comm 2003; 302: 415-420.
25. Imaizumi T, Kumagai M, Nishi N, et al. 15-deoxydelta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. Int Arch Allergy Immunol 2003; 131: 57-61.
26. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000; 403: 103-108.
27. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002; 2: 748-759.
28. Zhao ML, Brosnan CF, Lee SC. 15-deoxy-D(12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kB and MAP kinase pathways and suppression of cytokine and chemokine expression. J Neuroimmunol 2004; 153: 132-142.
29. Pritts EA, Zhao D, Sohn SH, Chao VA, Waite LL, Taylor RN. Peroxisome proliferators-activated receptor γ ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. Fertil Steril 2003; 80: 415-420.
30. 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J Immunol 2003; 171: 979-988.
31. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, Hart CM. Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 2005; 288: C899-C905.
32. Kim H, Kim KH. Transcriptional regulation by thiol compounds in Helicobacter pylori induced IL-8 production in human gastric epithelial cells. Ann N Y Acad Sci 2002; 973: 541-545.
33. Seo JH, Lim JW, Kim H, Kim KH. Helicobacter pylori in a Korean Isolate activates mitogen-activated protein kinases, AP-1, and NF-κB and induces chemokine expression in gastric epithelial AGS cells. Lab Invest 2004; 84: 49-62.
34. Chu SH, Kim H, Seo JY, Kim JW, Mukaida N, Kim KH. Role of NF-kB and AP-1 on Helicobacter pylori-induced IL-8 expression in AGS cells. Dig Dis Sci 2003; 48: 257-265.
35. Pierzchalski P, Pytko-Polonczyk J, Jaworek J, Konturek SJ, Gonciarz M. Only live Helicobacter pylori is capable of caspase-3 dependent apoptosis induction in gastric mucosa epithelial cells. J Physiol Pharmacol 2009; 60: 119-128.
36. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 1997; 113: 1009-1019.
37. 2+. New Phytologist 2001; 151: 185-194.
38. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976; 72: 248-254.
39. Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppress anchorage independent growth of HPV immortalized human keratnocytes. Oncogene 1998; 16: 2711-2721.
40. Kim OS, Park EJ, Joe EH, Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem 2002; 277: 40549-40601.
41. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Ann Rev Immunol 2000; 18: 143-164.
42. Narumiya S, Fukushima M. Site and mechanism of growth inhibition by prostaglandins. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther 1986; 239: 500-505.
43. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001; 7: 48-52.
44. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitor of IkappaB kinase. Nature 2000; 403: 103-108.
45. Oliva JL, Perez-Sala D, Castrillo A, et al. The cyclopentenone 15-deoxy-delta12, 14-prostaglandin J2 binds to and activates H-Ras. Proc Natl Acad Sci USA 2003; 100: 4772-4777.
46. Naito Y, Takagi T, Katada K, et al. Gastric peroxisome proliferator activator receptor-γ expression and cytoprotective actions of its ligands against ischemiareperfusion injury in rats. J Clin Biochem Nutr 2011; 48: 170-177.
47. Konturek PC, Brzozowski T, Kania J, et al. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat. Scand J Gastroenterol 2003; 38: 468-476.
48. Konturek PC, Brzozowski T, Kania J, et al. pioglitazone a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat. Eur J Pharmacol 2003; 472: 213-220.
49. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
50. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001; 7: 48-52.
51. Straus DS, Pascual G, Li M, et al. 5-deoxy-delta 12, 14- prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA 2000; 97: 4844-4849.
52. Takagi T, Naito Y, Ichikawa H, et al. A PPAR-gamma ligand, 15-deoxy-delta 12, 14-prostaglandin J2, inhibited gastric mucosal injury induced by ischemia-reperfusion in rats. Redox Rep 2004; 9: 376-381.
53. Slomiany BL, Slomiany A. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor γ activation. IUBMB Life 2002; 53: 303-308.